Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-14

Clinical Trial Update: The Effect of Morphine on Prasugrel Absorption in STEMI Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating how morphine affects prasugrel absorption in STEMI patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)
  • PRASUGREL (prasugrel)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Cardiovascular Disease | Phase 4 | Status: COMPLETED